The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
||||||||||||||||
| COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
| VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
| NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
| Achillion Pharmaceuticals Inc. | COM | 00448Q201 | 13,470 | 1,779,340 | SH | DFND | 3 | 1,779,340 | 0 | 0 | |
| Agios Pharmaceuticals Inc. | COM | 00847X104 | 23,185 | 506,000 | SH | DFND | 3 | 506,000 | 0 | 0 | |
| Alexion Pharmaceuticals Inc. | COM | 015351109 | 113,661 | 727,428 | SH | DFND | 2 | 727,428 | 0 | 0 | |
| Alnylam Pharmaceuticals Inc. | COM | 02043Q107 | 39,247 | 621,288 | SH | DFND | 3 | 621,288 | 0 | 0 | |
| Celgene Corp | COM | 151020104 | 362,353 | 4,219,298 | SH | DFND | 2 | 4,219,298 | 0 | 0 | |
| Clovis Oncology Inc | COM | 189464100 | 23,115 | 558,188 | SH | DFND | 3 | 558,188 | 0 | 0 | |
| Cubist Pharmaceuticals Inc. | RIGHT 99/99/9999 | 229678123 | 101 | 876,273 | SH | DFND | 3 | 876,273 | 0 | 0 | |
| Endocyte Inc. | COM | 29269A102 | 16,235 | 2,463,522 | SH | DFND | 3 | 2,463,522 | 0 | 0 | |
| Gilead Sciences Inc. | COM | 375558103 | 289,231 | 3,488,496 | SH | DFND | 1 | 3,488,496 | 0 | 0 | |
| Halozyme Therapeutics Inc. | COM | 40637H109 | 57,764 | 5,846,564 | SH | DFND | 3 | 5,846,564 | 0 | 0 | |
| ImmunoGen Inc. | COM | 45253H101 | 37,515 | 3,165,816 | SH | DFND | 3 | 3,165,816 | 0 | 0 | |
| Incyte Corp | COM | 45337C102 | 235,004 | 4,163,790 | SH | DFND | 3 | 4,163,790 | 0 | 0 | |
| Infinity Pharmaceuticals Inc. | COM | 45665G303 | 19,183 | 1,505,737 | SH | DFND | 3 | 1,505,737 | 0 | 0 | |
| Isis Pharmaceuticals Inc. | COM | 464330109 | 231,040 | 6,706,526 | SH | DFND | 3 | 6,706,526 | 0 | 0 | |
| Medivation Inc. | COM | 58501N101 | 115,597 | 1,499,706 | SH | DFND | 3 | 1,499,706 | 0 | 0 | |
| Neurocrine Biosciences Inc. | COM | 64125C109 | 45,789 | 3,086,552 | SH | DFND | 3 | 3,086,552 | 0 | 0 | |
| Pharmacyclics Inc. | COM | 716933106 | 65,627 | 731,542 | SH | DFND | 2 | 731,542 | 0 | 0 | |
| Puma Biotechnology Inc. | COM | 74587V107 | 38,081 | 576,991 | SH | DFND | 3 | 576,991 | 0 | 0 | |
| Radius Health Inc | COM | 750469207 | 35,686 | 2,745,040 | SH | DFND | 2,745,040 | 0 | 0 | ||
| Regeneron Pharmaceuticals Inc. | COM | 75886F107 | 65,816 | 233,000 | SH | DFND | 2 | 233,000 | 0 | 0 | |
| Synageva BioPharma Corp. | COM | 87159A103 | 94,160 | 898,476 | SH | DFND | 3 | 898,476 | 0 | 0 | |
| Tesaro Inc. | COM | 881569107 | 21,920 | 704,582 | SH | DFND | 3 | 704,582 | 0 | 0 | |
| Theravance Inc. | COM | 88338T104 | 27,792 | 933,244 | SH | DFND | 3 | 933,244 | 0 | 0 | |
| Vertex Pharmaceuticals Inc. | COM | 92532F100 | 132,973 | 1,404,445 | SH | DFND | 3 | 1,404,445 | 0 | 0 | |